IP Library Assignment 054853/0393
Patent Assignment
Reel/Frame 054853/0393

Assignment of Assignor's Interest

Recorded: 2021-01-08 Pages: 9
Assignor
PHIO PHARMACEUTICALS CORP.
Executed: 2020-12-16
Assignee
HAPTEN PHARMACEUTICALS, LLC
151 WEST 17TH STREET, SUITE 5A, NEW YORK, NEW YORK, 10011
Covered Properties (14)
Topical Immunomodulating Compositions for Treatment of Aids, Hepatitis B&C, Other Infectious Diseases, and Cancer
Patent: 6,455,586 →
Application: 09/459,935 →
Publication: US 2002/0128326
Gelled immunomodulating topical compositions and a method of treating warts and other human papilloma virus skin infections
Application: 11/228,569 →
Publication: US 2006/0211766
Effective Sensitizing Dose of a Gelled Immunomodulating Topical Composition
Application: 13/035,692 →
Publication: US 2011/0268761
Effective Sensitizing Dose of a Gelled Immunomodulating Topical Composition
Application: 14/532,694 →
Publication: US 2015/0057362
Methods for the Treatment of Alopecia Areata Utilizing Gene Modulation Approaches
Application: 15/532,804 →
Publication: US 2018/0263925
Methods for Treating Skin Disorders and Conditions Utilizing Haptens
Application: 15/758,576 →
Publication: US 2019/0029974
Effective Sensitizing Dose of a Gelled Immunomodulating Topical Composition
Application: 16/377,617 →
Publication: US 2020/0101028
Topical Immunomodulating Compositions for Treatment of Aids and Other Immunocompromised Diseases
Application: 60/112,363 →
Gelled immunomodulating topical compositions for treatment of warts and other human papilloma viral infections
Application: 60/614,577 →
Effective Sensitizing Dose of a Gelled Immunomodulating Topical Composition for the Treatment of Warts
Application: 61/309,717 →
Methods for the Treatment of Alopecia Areata Utilizing Gene Modulation Approaches
Application: 62/087,138 →
Methods for the Treatment of Alopecia Areata Utilizing Gene Modulation Approaches
Application: 62/095,309 →
Methods for Treating Skin Disorders and Conditions Utilizing Haptens
Application: 62/217,683 →
Methods for Treating Skin Disorders and Conditions Utilizing Haptens
Application: 62/262,871 →
Related Assignments (17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 14, 2011
From: LEVIS, WILLIAM R; KAPLAN, LEONARD L; CALLAHAN, JOHN G
To: HAPTEN PHARMACEUTICALS, LLC
Reel/Frame 026591/0792 →
Assignment of Assignor's Interest Oct 3, 2012
From: LEVIS, WILLIAM R. MD; KAPLAN, LEONARD L. PHD
To: HAPTEN PHARMACEUTICALS, LLC
Reel/Frame 029126/0426 →
Assignment of Assignor's Interest Jan 15, 2015
From: CAUWENBERGH, GERARD
To: RXI PHARMACEUTICALS CORPORATION
Reel/Frame 034728/0421 →
Assignment of Assignor's Interest Jun 19, 2015
From: HAPTEN PHARMACEUTICALS, LLC
To: RXI PHARMACEUTICALS CORPORATION
Reel/Frame 035865/0633 →
Assignment of Assignor's Interest Jul 9, 2015
From: CAUWENBERGH, GERARD
To: RXI PHARMACEUTICALS CORPORATION
Reel/Frame 036042/0730 →
Assignment of Assignor's Interest Aug 10, 2015
From: HAPTEN PHARMACEUTICALS, LLC
To: RXI PHARMACEUTICALS CORPORATION
Reel/Frame 036285/0218 →
Assignment of Assignor's Interest Aug 10, 2015
From: HAPTEN PHARMACEUTICALS, LLC
To: RXI PHARMACEUTICALS CORPORATION
Reel/Frame 036285/0227 →
Assignment of Assignor's Interest Aug 18, 2015
From: LEVIS, WILLIAM R.; KAPLAN, LEONARD L.; CALLAHAN, JOHN G.
To: HAPTEN PHARMACEUTICALS, LLC
Reel/Frame 036344/0977 →
Assignment of Assignor's Interest Feb 19, 2016
From: CAUWENBERGH, GERARD
To: RXI PHARMACEUTICALS CORPORATION
Reel/Frame 037778/0956 →
Assignment of Assignor's Interest Sep 6, 2016
From: JOHNSON, KEITH
To: RXI PHARMACEUTICALS CORPORATION
Reel/Frame 039641/0859 →
Assignment of Assignor's Interest Sep 9, 2016
From: CAUWENBERGH, GERARD
To: RXI PHARMACEUTICALS CORPORATION
Reel/Frame 039981/0494 →
Assignment of Assignor's Interest Nov 21, 2018
From: CAUWENBERGH, GERARD; JOHNSON, KEITH
To: RXI PHARMACEUTICALS CORPORATION
Reel/Frame 047616/0775 →
Change of Name Dec 7, 2018
From: RXI PHARMACEUTICALS CORPORATION
To: PHIO PHARMACEUTICALS CORP.
Reel/Frame 048380/0009 →
Change of Name May 17, 2019
From: RXI PHARMACEUTICALS CORPORATION
To: PHIO PHARMACEUTICALS CORP.
Reel/Frame 049219/0367 →
Assignment of Assignor's Interest May 17, 2019
From: LEVIS, WILLIAM R.; KAPLAN, LEONARD L.; CALLAHAN, JOHN G.
To: HAPTEN PHARMACEUTICALS, LLC
Reel/Frame 049205/0698 →
Assignment of Assignor's Interest May 17, 2019
From: HAPTEN PHARMACEUTICALS, LLC
To: RXI PHARMACEUTICALS CORPORATION
Reel/Frame 049205/0695 →
Assignment of Assignor's Interest May 22, 2019
From: CAUWENBERGH, GERARD; JOHNSON, KEITH
To: PHIO PHARMACEUTICALS CORP.
Reel/Frame 049254/0060 →